Needham & Company analyst Mike Matson lowered the price target on Veracyte, Inc (NASDAQ: VCYT) to $26.00 (from $31.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS View Analyst PT Change

Form 10-Q VERACYTE, INC. For: Mar 31May 4, 2022 6:02 AM Veracyte, Inc (VCYT) PT Lowered to $30 at Raymond JamesMay 4, 2022 5:54 AM Veracyte, Inc (VCYT) PT Lowered to $23 at Morgan StanleyMay 4, 2022 3:40 AM Form 4 VERACYTE, INC. For: May 01 Filed by: Anderson Bonnie HMay 3, 2022 5:44 PM Veracyte (VCYT) Tops Q1 EPS by 4cMay 3, 2022 4:40 PM Form 8-K VERACYTE, INC. For: May 03May 3, 2022 4:13 PM Veracyte Announces First Quarter 2022 Financial ResultsMay 3, 2022 4:05 PM